Flora Growth Corp FLGC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.37
- Day Range
- $1.20–1.42
- 52-Week Range
- $0.63–2.93
- Bid/Ask
- $1.25 / $1.30
- Market Cap
- $16.98 Mil
- Volume/Avg
- 193,343 / 87,117
Key Statistics
- Price/Earnings (Normalized)
- 0.53
- Price/Sales
- 0.17
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 108
- Website
- https://www.floragrowth.com
Valuation
|
Metric
|
FLGC
|
|---|---|
Price/Earnings (Normalized) | 0.53 |
Price/Book Value | 2.32 |
Price/Sales | 0.17 |
Price/Cash Flow | — |
Price/Earnings
FLGC
Financial Strength
|
Metric
|
FLGC
|
|---|---|
Quick Ratio | 0.74 |
Current Ratio | 1.16 |
Interest Coverage | −337.45 |
Quick Ratio
FLGC
Profitability
|
Metric
|
FLGC
|
|---|---|
Return on Assets (Normalized) | −24.15% |
Return on Equity (Normalized) | −80.34% |
Return on Invested Capital (Normalized) | −53.71% |
Return on Assets
FLGC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Mvnzwjbgl | Ztfp | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Xwmmqjhtd | Lpgtqc | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Dvnysby | Lvv | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Ngzktnxlx | Frgqg | $19.0 Bil | |||
| Viatris Inc
VTRS
| Txhtybld | Nnwdy | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Kmhfnxmp | Xgqw | $13.4 Bil | |||
| Catalent Inc
CTLT
| Qcrpnjgqn | Llnvv | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Jtjxdjhr | Llvklkv | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Btsqnsbzf | Nlp | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Cyynlysq | Bwztd | $2.5 Bil |
United States